BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15353114)

  • 1. Local infections after above-knee prosthetic femoropopliteal bypass for intermittent claudication.
    Pedersen G; Laxdal E; Hagala M; Aune S
    Surg Infect (Larchmt); 2004; 5(2):174-9. PubMed ID: 15353114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Above-knee prosthetic femoropopliteal bypass for intermittent claudication. Results of the initial and secondary procedures.
    Aune S; Laxdal E
    Eur J Vasc Endovasc Surg; 2000 May; 19(5):476-80. PubMed ID: 10828227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of the FUSION vascular graft for above-knee femoropopliteal bypass.
    Assadian A; Eckstein HH;
    J Vasc Surg; 2015 Mar; 61(3):713-9.e1. PubMed ID: 25498193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of comorbidity on long-term results of above-knee prosthetic femoropopliteal bypass for intermittent claudication.
    Pedersen G; Laxdal E; Hagala M; Aune S
    Int Angiol; 2005 Sep; 24(3):245-9. PubMed ID: 16158033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Femoropopliteal bypass with a compliant, composite polyurethane/Dacron graft: short-term results of a multicentre trial.
    Dereume JP; van Romphey A; Vincent G; Engelmann E
    Cardiovasc Surg; 1993 Oct; 1(5):499-503. PubMed ID: 8076085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes in the management of vascular prosthetic graft infections confined to the groin: a reappraisal.
    Taylor SM; Weatherford DA; Langan EM; Lokey JS
    Ann Vasc Surg; 1996 Mar; 10(2):117-22. PubMed ID: 8733862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prosthetic above-knee femoropopliteal bypass for intermittent claudication.
    Rosenthal D; Evans RD; McKinsey J; Seagraves MA; Lamis PA; Clark MD; Daniel WW
    J Cardiovasc Surg (Torino); 1990; 31(4):462-8. PubMed ID: 2145288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis to compare Dacron versus polytetrafluroethylene grafts for above-knee femoropopliteal artery bypass.
    Rychlik IJ; Davey P; Murphy J; O'Donnell ME
    J Vasc Surg; 2014 Aug; 60(2):506-15. PubMed ID: 24973288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoluminal femoropopliteal bypass for intermittent claudication.
    Tisi PV; Cowan AR; Morris GE
    Eur J Vasc Endovasc Surg; 2000 May; 19(5):481-8. PubMed ID: 10828228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional outcome after surgical treatment for intermittent claudication.
    Zannetti S; L'Italien GJ; Cambria RP
    J Vasc Surg; 1996 Jul; 24(1):65-73. PubMed ID: 8691530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Femoropopliteal reconstruction for obliterative arteriosclerosis. A 6-year surgical material].
    Aune S; Trippestad A
    Tidsskr Nor Laegeforen; 1993 May; 113(12):1458-61. PubMed ID: 8332972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polytetrafluoroethylene versus human umbilical vein in above-knee femoropopliteal bypass: six-year results of a randomized clinical trial.
    Aalders GJ; van Vroonhoven TJ
    J Vasc Surg; 1992 Dec; 16(6):816-23; discussion 823-4. PubMed ID: 1460707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial comparing the safety and efficacy between the FUSION BIOLINE heparin-coated vascular graft and the standard expanded polytetrafluoroethylene graft for femoropopliteal bypass.
    Lumsden AB; Morrissey NJ;
    J Vasc Surg; 2015 Mar; 61(3):703-12.e1. PubMed ID: 25720929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The preferential use of the external iliac artery as an inflow source for redo femoropopliteal and infrapopliteal bypass.
    Ascer E; Kirwin J; Mohan C; Gennaro M
    J Vasc Surg; 1993 Aug; 18(2):234-9; discussion 239-41. PubMed ID: 8350432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expanded polytetrafluoroethylene femoropopliteal grafts: forty-eight-month follow-up.
    Evans LE; Webster MW; Brooks DH; Bahnson HT
    Surgery; 1981 Jan; 89(1):16-22. PubMed ID: 7466607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case study: chronic femoropopliteal prosthetic graft infection with exposed graft.
    McCready RA; Bryant MA; Divelbiss J; Wack MF; Mattison HR
    Vasc Endovascular Surg; 2009; 43(3):291-4. PubMed ID: 19190040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidural abscess formation as a complication of femoropopliteal bypass graft infection.
    Parry DJ; Giles M; Souka H; Aldoori MI
    Eur J Vasc Endovasc Surg; 2000 Jun; 19(6):671-2. PubMed ID: 10873740
    [No Abstract]   [Full Text] [Related]  

  • 19. Femoropopliteal bypass grafting for intermittent claudication: is pessimism warranted?
    Donaldson MC; Mannick JA
    Arch Surg; 1980 Jun; 115(6):724-7. PubMed ID: 7387359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ replacement of vascular prostheses infected by bacterial biofilms.
    Bandyk DF; Bergamini TM; Kinney EV; Seabrook GR; Towne JB
    J Vasc Surg; 1991 May; 13(5):575-83. PubMed ID: 2027196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.